LANDOS BIOPHARMA Trademark

Trademark Overview


On Thursday, March 21, 2019, a trademark application was filed for LANDOS BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the LANDOS BIOPHARMA trademark a serial number of 88350574. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 24, 2026. This trademark is owned by Landos Biopharma, Inc. The LANDOS BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

biopharmaceutical services, namely, research, development and testing of therapeutics for patients with diseases
landos biopharma

General Information


Serial Number88350574
Word MarkLANDOS BIOPHARMA
Filing DateThursday, March 21, 2019
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 24, 2026
Registration Number5879103
Registration DateTuesday, October 8, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements


Description of MarkThe mark consists of a shield having three sections, wherein the upper third section is colored orange, the lower third includes a red and white cross hatch pattern and the middle third section has the appearance of a pointed slash positioned from the lower left portion to the upper right portion of the shield, wherein the slash includes a red border encompassing multiple solid blue circles of varying sizes over a white background, the shield being accompanied by the words "LANDOS BIOPHARMA" in black to the right of the shield.
NOT AVAILABLE"BIOPHARMA"
Indication of Colors claimedThe color(s) orange, red, blue, white and black is/are claimed as a feature of the mark.
Pseudo MarkLANDOS BIO PHARMA
Goods and Servicesbiopharmaceutical services, namely, research, development and testing of therapeutics for patients with diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 24, 2026
Primary Code042
First Use Anywhere DateWednesday, February 22, 2017
First Use In Commerce DateWednesday, February 22, 2017

Trademark Owner History


Party NameLandos Biopharma, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060
US

Party NameLandos Biopharma, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060
US

Party NameLandos Biopharma, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060
US

Trademark Events


Event DateEvent Description
Monday, March 25, 2019NEW APPLICATION ENTERED
Monday, April 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 9, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, June 2, 2019ASSIGNED TO EXAMINER
Monday, June 3, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, June 3, 2019EXAMINERS AMENDMENT E-MAILED
Monday, June 3, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 3, 2019EXAMINER'S AMENDMENT ENTERED
Monday, June 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 17, 2019ASSIGNED TO LIE
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Monday, August 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 8, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 24, 2026CANCELLED SEC. 8 (6-YR)